Sabrina Serani - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Sabrina Serani's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Sabrina Serani

Sabrina Serani

Verified

Senior Editor, Targeted Oncology

New York

Final Covers

Health , Environment , Science , Technology

Doesn’t Cover

Wine and spirits

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 748

  • FDA Grants Novel Therapy RMAT Designation for Dysphagia Following Head and Neck Cancer Treatment

    By Sabrina Serani Verified

    Apr. 16, 2025

  • FDA Oks Sotorasib/Panitumumab in KRAS G12C-Mutant Colorectal Cancer

    By Sabrina Serani Verified, Jordyn Sava Verified

    Jan. 16, 2025

  • FDA Grants Novel Therapy RMAT Designation for Dysphagia Following Head and Neck Cancer Treatment

    By Sabrina Serani Verified

    Apr. 16, 2025

As seen in

Company Info

Targeted Oncology

Targeted Oncology is a key resource for oncology healthcare professionals, especially community oncologists. It provides valuable information on targeted therapies and immunotherapies in cancer treatment. As a brand under MJH Life Sciences, it is part of the largest privately held, independent medical media company in North America. The company offers a variety of services, including digital and print media that feature news and expert opinions on precision medicine in oncology. Targeted Oncology also hosts over 800 educational events each year, such as Case-Based Roundtable and Community Case Forum events, which facilitate networking and discussions among oncologists and hematologists. Additionally, it provides diverse content formats, including articles, videos, and podcasts, aimed at enhancing learning and practice outcomes in the field of oncology.

, ,

'+1 609-716-7777

Founded: 2012